DEXTROMETHORPHAN POLISTIREX

DEXTROMETHORPHAN POLISTIREX was reported 757 times

DEXTROMETHORPHAN POLISTIREX is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FOETAL HEART RATE INCREASED 1 0.0114
1 METAPNEUMOVIRUS PNEUMONIA 1 0.0104
2 PELVIC DEFORMITY 1 0.0078
3 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0044
4 INCREASED INSULIN REQUIREMENT 1 0.0042
5 PHARYNGITIS BACTERIAL 1 0.0039
6 OMPHALITIS 1 0.0035
7 THERAPEUTIC DRUG MONITORING ANALYSIS NOT PERFORMED 1 0.0034
8 URETHRAL OBSTRUCTION 1 0.0025
9 EAR MALFORMATION 1 0.0022
10 FOETAL HEART RATE DECREASED 1 0.0016
11 GLOMERULOSCLEROSIS 1 0.0016
12 GASTROINTESTINAL MUCOSAL DISORDER 1 0.0015
13 PROCEDURAL ANXIETY 1 0.0015
14 POSITRON EMISSION TOMOGRAM ABNORMAL 1 0.0014
15 PARASOMNIA 1 0.0014
16 LARYNGEAL DISORDER 1 0.0014
17 DISSOCIATIVE DISORDER 1 0.0014
18 AMNIOTIC CAVITY INFECTION 1 0.0014
19 REACTION TO PRESERVATIVES 1 0.0012
20 SALIVA ALTERED 1 0.0011
21 PHARYNGEAL HYPOAESTHESIA 1 0.0011
22 DRUG ADMINISTERED IN WRONG DEVICE 1 0.0010
23 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
24 ALVEOLITIS ALLERGIC 1 0.0010
25 DRUG EFFECT INCOMPLETE 34 0.0009
26 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 6 0.0009
27 GASTROINTESTINAL BACTERIAL INFECTION 1 0.0009
28 HYPERAESTHESIA TEETH 1 0.0008
29 NOCTURNAL DYSPNOEA 1 0.0008
30 PRODUCT EXPIRATION DATE ISSUE 1 0.0007
31 NORMOCYTIC ANAEMIA 1 0.0007
32 LIMB DEFORMITY 1 0.0006
33 SPINAL DEFORMITY 1 0.0006
34 SLEEP TALKING 1 0.0006
35 MILIARIA 1 0.0006
36 BODY TEMPERATURE ABNORMAL 1 0.0005
37 CATHETER PLACEMENT 1 0.0005
38 LIP DISORDER 1 0.0005
39 PRODUCT TASTE ABNORMAL 7 0.0005
40 BICYTOPENIA 1 0.0005
41 ENERGY INCREASED 3 0.0005
42 IDIOPATHIC PULMONARY FIBROSIS 2 0.0005
43 LIPIDS INCREASED 1 0.0005
44 WALKING DISABILITY 1 0.0005
45 PHARYNGEAL ERYTHEMA 1 0.0005
46 MYDRIASIS 6 0.0005
47 EXOPHTHALMOS 1 0.0005
48 LIMB MASS 1 0.0005
49 PRODUCT LOT NUMBER ISSUE 1 0.0005
50 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 1 0.0004
51 LICHENOID KERATOSIS 1 0.0004
52 EYELID DISORDER 1 0.0004
53 NECK SURGERY 1 0.0004
54 OXYGEN CONSUMPTION INCREASED 1 0.0004
55 STARING 1 0.0004
56 SLOW SPEECH 1 0.0004
57 FEELING DRUNK 3 0.0004
58 THERAPEUTIC RESPONSE SHORTENED 13 0.0004
59 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
60 ALCOHOL POISONING 1 0.0004
61 BLOOD SODIUM INCREASED 1 0.0004
62 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
63 OXYGEN SATURATION ABNORMAL 1 0.0004
64 LIP PAIN 1 0.0003
65 PULMONARY PAIN 1 0.0003
66 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
67 BRAIN DEATH 1 0.0003
68 NASAL DRYNESS 2 0.0003
69 CUSHINGOID 1 0.0003
70 PLASMA CELL MYELOMA RECURRENT 1 0.0003
71 NEOPLASM RECURRENCE 1 0.0003
72 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
73 HYPOPNOEA 1 0.0003
74 FORMICATION 2 0.0003
75 HANGOVER 1 0.0003
76 APPARENT DEATH 1 0.0003
77 PARADOXICAL DRUG REACTION 1 0.0003
78 HYPERACUSIS 1 0.0003
79 APHTHOUS ULCER 2 0.0003
80 MULTIPLE ALLERGIES 2 0.0003
81 NAIL DISCOLOURATION 1 0.0003
82 RESPIRATORY ACIDOSIS 1 0.0003
83 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 18 0.0003
84 OESOPHAGEAL CANDIDIASIS 1 0.0003
85 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
86 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
87 RETCHING 5 0.0002
88 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
89 OCULAR ICTERUS 1 0.0002
90 CHAPPED LIPS 1 0.0002
91 ONYCHOMYCOSIS 1 0.0002
92 GINGIVAL SWELLING 1 0.0002
93 DRUG EFFECT DELAYED 1 0.0002
94 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
95 RENAL FUNCTION TEST ABNORMAL 1 0.0002
96 DRUG INEFFECTIVE 278 0.0002
97 EXPIRED PRODUCT ADMINISTERED 7 0.0002
98 FEELING JITTERY 4 0.0002
99 GESTATIONAL DIABETES 1 0.0002
100 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
101 INCORRECT DOSAGE ADMINISTERED 1 0.0002
102 HYPERNATRAEMIA 1 0.0002
103 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
104 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
105 DRUG TOLERANCE 1 0.0002
106 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
107 DRY THROAT 2 0.0002
108 FAILURE TO THRIVE 1 0.0002
109 EYE DISCHARGE 2 0.0002
110 PRODUCT RESIDUE PRESENT 1 0.0002
111 CHEILITIS 1 0.0002
112 JAW DISORDER 1 0.0002
113 ANGIOPATHY 1 0.0002
114 HYPOVOLAEMIA 1 0.0002
115 URINE ODOUR ABNORMAL 1 0.0002
116 DECREASED INTEREST 1 0.0002
117 SCOLIOSIS 1 0.0002
118 INFUSION SITE EXTRAVASATION 1 0.0002
119 THERAPEUTIC RESPONSE CHANGED 1 0.0002
120 FOREIGN BODY SENSATION IN EYES 1 0.0002
121 HYPERSENSITIVITY 29 0.0002
122 UNRESPONSIVE TO STIMULI 4 0.0002
123 ORAL HERPES 3 0.0002
124 PRODUCT FORMULATION ISSUE 1 0.0002
125 ABNORMAL BEHAVIOUR 6 0.0002
126 CARDIAC FAILURE ACUTE 1 0.0001
127 PRODUCT LABEL ISSUE 1 0.0001
128 MATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0001
129 ONYCHOCLASIS 1 0.0001
130 AUTOIMMUNE HEPATITIS 1 0.0001
131 APHONIA 2 0.0001
132 CARPAL TUNNEL SYNDROME 2 0.0001
133 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
134 SEASONAL ALLERGY 2 0.0001
135 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
136 SOMNOLENCE 28 0.0001
137 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
138 HYDRONEPHROSIS 1 0.0001
139 LIPASE INCREASED 1 0.0001
140 FURUNCLE 1 0.0001
141 NASAL DISCOMFORT 1 0.0001
142 RHINITIS 1 0.0001
143 EXTRA DOSE ADMINISTERED 5 0.0001
144 PRESYNCOPE 3 0.0001
145 UNDERDOSE 9 0.0001
146 DIARRHOEA 79 0.0001
147 LIP SWELLING 4 0.0001
148 SENSATION OF FOREIGN BODY 1 0.0001
149 INCORRECT DOSE ADMINISTERED 27 0.0001
150 BLOOD MAGNESIUM DECREASED 1 0.0001
151 PSYCHOLOGICAL TRAUMA 1 0.0001
152 BALANCE DISORDER 10 0.0001
153 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
154 GROIN PAIN 1 0.0001
155 LUNG INFILTRATION 1 0.0001
156 HEAD DISCOMFORT 2 0.0001
157 FACIAL PAIN 1 0.0001
158 OROPHARYNGEAL DISCOMFORT 1 0.0001
159 ACCIDENTAL OVERDOSE 4 0.0001
160 ABNORMAL DREAMS 3 0.0001
161 AUTOIMMUNE DISORDER 1 0.0001
162 INFLAMMATORY BOWEL DISEASE 1 0.0001
163 PHARYNGEAL SWELLING 1 0.0001
164 RENAL TUBULAR NECROSIS 1 0.0001
165 HEPATOMEGALY 1 0.0001
166 BLOOD POTASSIUM DECREASED 3 0.0001
167 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
168 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 7 0.0001
169 MOTOR DYSFUNCTION 1 0.0001
170 SLUGGISHNESS 1 0.0001
171 EUPHORIC MOOD 1 0.0001
172 INITIAL INSOMNIA 1 0.0001
173 EAR DISCOMFORT 1 0.0001
174 FEELING ABNORMAL 23 0.0001
175 HALLUCINATION, VISUAL 2 0.0001
176 RENAL PAIN 1 0.0001
177 HEREDITARY ANGIOEDEMA 1 0.0001
178 FAECES DISCOLOURED 2 0.0001
179 SKIN LACERATION 1 0.0001
180 URINARY RETENTION 3 0.0001
181 BLOOD CALCIUM DECREASED 1 0.0001
182 IMPAIRED DRIVING ABILITY 1 0.0001
183 MYOCARDIAL ISCHAEMIA 1 0.0001
184 MICTURITION URGENCY 1 0.0001
185 INTERNAL HAEMORRHAGE 1 0.0001
186 CAESAREAN SECTION 1 0.0001
187 CONDITION AGGRAVATED 26 0.0001
188 COVID-19 PNEUMONIA 1 0.0001
189 ATAXIA 1 0.0001
190 DIZZINESS 42 0.0001
191 PRODUCTIVE COUGH 4 0.0001
192 MACULAR DEGENERATION 1 0.0001
193 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 15 0.0001
194 CARDIOMEGALY 1 0.0001
195 SPINAL OPERATION 1 0.0001
196 HAIR COLOUR CHANGES 1 0.0001
197 POISONING 1 0.0001
198 ROTATOR CUFF SYNDROME 1 0.0001
199 HIATUS HERNIA 1 0.0001
200 SEDATION 2 0.0001
201 ORAL CANDIDIASIS 1 0.0001
202 THROAT TIGHTNESS 2 0.0001
203 ABDOMINAL PAIN UPPER 15 0.0001
204 PERIPHERAL COLDNESS 1 0.0001
205 RESPIRATORY DISTRESS 2 0.0001
206 INTENTIONAL DOSE OMISSION 2 0.0001
207 HYPERSOMNIA 2 0.0001
208 OVERDOSE 15 0.0001
209 LETHARGY 4 0.0001
210 HYPOKINESIA 1 0.0001
211 PULMONARY MASS 1 0.0001
212 THROAT IRRITATION 3 0.0001
213 HEPATIC FAILURE 2 0.0001
214 DRUG ADMINISTRATION ERROR 2 0.0001
215 PHARYNGEAL OEDEMA 1 0.0001
216 OROPHARYNGEAL PAIN 6 0.0001
217 THERAPY PARTIAL RESPONDER 1 0.0001
218 BRAIN FOG 1 0.0001
219 HIP FRACTURE 2 0.0001
220 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
221 BACK DISORDER 1 0.0001
222 CHOLELITHIASIS 2 0.0001
223 VIRAL INFECTION 2 0.0001
224 INSOMNIA 16 0.0001
225 CONSTIPATION 13 0.0001
226 EYE PRURITUS 2 0.0001
227 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
228 VISION BLURRED 8 0.0001
229 RASH MACULAR 2 0.0001
230 COLD SWEAT 1 0.0001
231 GOUT 1 0.0001
232 GASTROENTERITIS VIRAL 1 0.0001
233 TOOTHACHE 1 0.0001
234 PANIC ATTACK 2 0.0001
235 END STAGE RENAL DISEASE 1 0.0001
236 EYE SWELLING 2 0.0001
237 URTICARIA 9 0.0001
238 THINKING ABNORMAL 1 0.0001
239 MIDDLE INSOMNIA 1 0.0001
240 HYPOAESTHESIA 8 0.0001
241 OXYGEN SATURATION DECREASED 3 0.0001
242 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
243 PHOTOPHOBIA 1 0.0001
244 HYPOCALCAEMIA 1 0.0001
245 GASTRIC ULCER 1 0.0001
246 HAEMORRHOIDS 1 0.0001
247 VOMITING 24 0.0001
248 DYSPEPSIA 5 0.0001
249 NAUSEA 40 0.0001
250 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
251 HEART RATE INCREASED 5 0.0001
252 BLOOD PRESSURE ABNORMAL 1 0.0001
253 MALAISE 22 0.0001
254 COUGH 14 0.0000
255 PRODUCT ADMINISTRATION ERROR 1 0.0000
256 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10 0.0000
257 FEEDING DISORDER 1 0.0000
258 RIB FRACTURE 1 0.0000
259 PULMONARY HYPERTENSION 1 0.0000
260 IMPAIRED WORK ABILITY 1 0.0000
261 IRRITABLE BOWEL SYNDROME 1 0.0000
262 POOR QUALITY SLEEP 1 0.0000
263 RHINORRHOEA 3 0.0000
264 BLOOD PRESSURE INCREASED 7 0.0000
265 RASH MACULO-PAPULAR 1 0.0000
266 HEPATOTOXICITY 1 0.0000
267 PULMONARY OEDEMA 2 0.0000
268 ORAL PAIN 1 0.0000
269 SNEEZING 1 0.0000
270 CHROMATURIA 1 0.0000
271 ASTHMA 5 0.0000
272 BLOOD GLUCOSE INCREASED 8 0.0000
273 DISEASE RECURRENCE 2 0.0000
274 ABDOMINAL DISCOMFORT 7 0.0000
275 LOCALISED INFECTION 1 0.0000
276 RASH 18 0.0000
277 MENTAL IMPAIRMENT 1 0.0000
278 NEURALGIA 1 0.0000
279 LUNG DISORDER 2 0.0000
280 ENCEPHALOPATHY 1 0.0000
281 DYSGEUSIA 3 0.0000
282 SINUSITIS 4 0.0000
283 ILLNESS 4 0.0000
284 SKIN ULCER 1 0.0000
285 EXPOSURE VIA SKIN CONTACT 1 0.0000
286 RESPIRATORY TRACT INFECTION 1 0.0000
287 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
288 NERVOUSNESS 2 0.0000
289 SPEECH DISORDER 2 0.0000
290 PARAESTHESIA 6 0.0000
291 RENAL FAILURE 5 0.0000
292 ASTHENIA 14 0.0000
293 FEAR 1 0.0000
294 DRUG EFFECT DECREASED 2 0.0000
295 CONFUSIONAL STATE 6 0.0000
296 DISTURBANCE IN ATTENTION 2 0.0000
297 PNEUMONIA 12 0.0000
298 BLOOD BILIRUBIN INCREASED 1 0.0000
299 FREQUENT BOWEL MOVEMENTS 1 0.0000
300 DRY MOUTH 3 0.0000
301 PALLOR 1 0.0000
302 PRURITUS 14 0.0000
303 RESPIRATORY ARREST 1 0.0000
304 TREMOR 6 0.0000
305 FEELING COLD 1 0.0000
306 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
307 RED BLOOD CELL COUNT DECREASED 1 0.0000
308 HERPES ZOSTER 2 0.0000
309 EYE IRRITATION 2 0.0000
310 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
311 DYSPHONIA 2 0.0000
312 URINARY INCONTINENCE 1 0.0000
313 RESPIRATORY DISORDER 1 0.0000
314 LACRIMATION INCREASED 1 0.0000
315 PLEURAL EFFUSION 2 0.0000
316 VERTIGO 2 0.0000
317 DISCOMFORT 2 0.0000
318 PERIPHERAL SWELLING 5 0.0000
319 LIMB DISCOMFORT 1 0.0000
320 SWOLLEN TONGUE 1 0.0000
321 BONE DENSITY DECREASED 1 0.0000
322 HEAD INJURY 1 0.0000
323 GAIT DISTURBANCE 6 0.0000
324 HYPOTHYROIDISM 1 0.0000
325 AMNESIA 2 0.0000
326 PRODUCT DOSE OMISSION 2 0.0000
327 EYE DISORDER 1 0.0000
328 INFUSION RELATED REACTION 2 0.0000
329 GAIT INABILITY 1 0.0000
330 ERYTHEMA 6 0.0000
331 DELIRIUM 1 0.0000
332 ABDOMINAL DISTENSION 3 0.0000
333 HYPERKALAEMIA 1 0.0000
334 COVID-19 5 0.0000
335 HYPOXIA 1 0.0000
336 PRODUCT USE IN UNAPPROVED INDICATION 7 0.0000
337 RESPIRATORY FAILURE 2 0.0000
338 MUSCLE SPASMS 5 0.0000
339 DYSURIA 1 0.0000
340 NASOPHARYNGITIS 5 0.0000
341 DYSARTHRIA 1 0.0000
342 DYSPNOEA EXERTIONAL 1 0.0000
343 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
344 SEIZURE 3 0.0000
345 DISORIENTATION 1 0.0000
346 DRUG INTERACTION 4 0.0000
347 INJECTION SITE BRUISING 2 0.0000
348 HEADACHE 15 0.0000
349 HYPERHIDROSIS 3 0.0000
350 RECTAL HAEMORRHAGE 1 0.0000
351 PYREXIA 8 0.0000
352 MENTAL DISORDER 1 0.0000
353 DEHYDRATION 3 0.0000
354 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
355 GASTROINTESTINAL DISORDER 2 0.0000
356 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
357 TINNITUS 1 0.0000
358 SKIN DISCOLOURATION 1 0.0000
359 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
360 DECREASED APPETITE 5 0.0000
361 ANXIETY 6 0.0000
362 OCULAR HYPERAEMIA 1 0.0000
363 DYSPHAGIA 2 0.0000
364 COMA 1 0.0000
365 RASH ERYTHEMATOUS 1 0.0000
366 INTERSTITIAL LUNG DISEASE 1 0.0000
367 FATIGUE 16 0.0000
368 ALOPECIA 4 0.0000
369 AGGRESSION 1 0.0000
370 FLUID RETENTION 1 0.0000
371 MUSCULOSKELETAL PAIN 1 0.0000
372 PANCREATITIS 1 0.0000
373 DEPRESSED MOOD 1 0.0000
374 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
375 PLATELET COUNT DECREASED 2 0.0000
376 DRUG DEPENDENCE 3 0.0000
377 RASH PRURITIC 1 0.0000
378 OEDEMA 1 0.0000
379 ANAPHYLACTIC REACTION 1 0.0000
380 FALL 6 0.0000
381 MEDICATION ERROR 1 0.0000
382 PANCYTOPENIA 1 0.0000
383 TOXICITY TO VARIOUS AGENTS 3 0.0000
384 FLATULENCE 1 0.0000
385 MUSCULAR WEAKNESS 2 0.0000
386 PRODUCT SUBSTITUTION ISSUE 1 0.0000
387 PALPITATIONS 2 0.0000
388 BLADDER CANCER 1 0.0000
389 WHEEZING 1 0.0000
390 IRRITABILITY 1 0.0000
391 EMOTIONAL DISTRESS 2 0.0000
392 THERAPEUTIC RESPONSE DECREASED 1 0.0000
393 SUICIDE ATTEMPT 1 0.0000
394 FEELING HOT 1 0.0000
395 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
396 EXPOSURE DURING PREGNANCY 1 0.0000
397 DYSPNOEA 9 0.0000
398 LOSS OF CONSCIOUSNESS 2 0.0000
399 SWELLING FACE 1 0.0000
400 BLOOD PRESSURE DECREASED 1 0.0000
401 HEPATIC ENZYME INCREASED 1 0.0000
402 DEVICE MALFUNCTION 1 0.0000
403 AGITATION 1 0.0000
404 PAIN IN EXTREMITY 4 0.0000
405 HALLUCINATION 1 0.0000
406 HOT FLUSH 1 0.0000
407 UNEVALUABLE EVENT 1 0.0000
408 CHRONIC KIDNEY DISEASE 1 0.0000
409 DIABETES MELLITUS 1 0.0000
410 PAIN 8 0.0000
411 ABDOMINAL PAIN 3 0.0000
412 ARTHRITIS 1 0.0000
413 CARDIAC FAILURE 1 0.0000
414 PROSTATE CANCER 1 0.0000
415 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
416 INFLUENZA LIKE ILLNESS 1 0.0000
417 DRUG ABUSE 1 0.0000
418 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
419 PRODUCT STORAGE ERROR 1 0.0000
420 INTENTIONAL PRODUCT MISUSE 1 0.0000
421 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
422 ADVERSE EVENT 1 0.0000
423 CHEST PAIN 2 0.0000
424 CARDIAC DISORDER 1 0.0000
425 NEUROPATHY PERIPHERAL 1 0.0000
426 ANAEMIA 2 0.0000
427 MIGRAINE 1 0.0000
428 CONTUSION 1 0.0000
429 DRUG INTOLERANCE 1 0.0000
430 ATRIAL FIBRILLATION 1 0.0000
431 PRODUCT DOSE OMISSION ISSUE 3 0.0000
432 CHEST DISCOMFORT 1 0.0000
433 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
434 ARTHRALGIA 4 0.0000
435 HAEMORRHAGE 1 0.0000
436 HYPERTENSION 2 0.0000
437 INFLUENZA 1 0.0000
438 THROMBOCYTOPENIA 1 0.0000
439 WEIGHT INCREASED 2 0.0000
440 DEPRESSION 2 0.0000
441 BACK PAIN 2 0.0000
442 JOINT SWELLING 1 0.0000
443 OEDEMA PERIPHERAL 1 0.0000
444 VISUAL IMPAIRMENT 1 0.0000
445 OFF LABEL USE 7 0.0000
446 DRY SKIN 1 0.0000
447 NEUTROPENIA 1 0.0000
448 MEMORY IMPAIRMENT 1 0.0000
449 WEIGHT DECREASED 2 0.0000
450 INFECTION 1 0.0000
451 ACUTE KIDNEY INJURY 1 0.0000
452 HOSPITALISATION 1 0.0000
453 CEREBROVASCULAR ACCIDENT 1 0.0000
454 MYALGIA 1 0.0000
455 URINARY TRACT INFECTION 1 0.0000
456 DEATH 5 0.0000
457 MYOCARDIAL INFARCTION 1 0.0000
458 NO ADVERSE EVENT 1 0.0000
459 PRODUCT USE ISSUE 1 0.0000
460 HYPOTENSION 1 0.0000
461 INJECTION SITE PAIN 1 0.0000